New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome - PubMed (original) (raw)
New International Diabetes Federation (IDF) and National Cholesterol Education Program Adult Treatment panel III (NCEP-ATPIII) criteria and the involvement of hemostasis and fibrinolysis in the metabolic syndrome
I Mertens et al. J Thromb Haemost. 2006 May.
Free article
No abstract available
Similar articles
- The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC, Ozaki R, Chow CC, Lam CW, Chan JC, Cockram CS. Tong PC, et al. Diabetes Care. 2007 May;30(5):1206-11. doi: 10.2337/dc06-1484. Epub 2007 Jan 26. Diabetes Care. 2007. PMID: 17259472 - Prevalence of metabolic syndrome in type 2 diabetes mellitus using NCEP-ATPIII, IDF and WHO definition and its agreement in Gwalior Chambal region of Central India.
Yadav D, Mahajan S, Subramanian SK, Bisen PS, Chung CH, Prasad GB. Yadav D, et al. Glob J Health Sci. 2013 Sep 17;5(6):142-55. doi: 10.5539/gjhs.v5n6p142. Glob J Health Sci. 2013. PMID: 24171882 Free PMC article. - Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. Mertens I, et al. Int J Obes (Lond). 2006 Aug;30(8):1308-14. doi: 10.1038/sj.ijo.0803189. Epub 2006 Jan 3. Int J Obes (Lond). 2006. PMID: 16389265 - Obesity, haemostasis and the fibrinolytic system.
Mertens I, Van Gaal LF. Mertens I, et al. Obes Rev. 2002 May;3(2):85-101. doi: 10.1046/j.1467-789x.2002.00056.x. Obes Rev. 2002. PMID: 12120424 Review. - von Willebrand factor and fibrinogen.
Ruggeri ZM. Ruggeri ZM. Curr Opin Cell Biol. 1993 Oct;5(5):898-906. doi: 10.1016/0955-0674(93)90041-n. Curr Opin Cell Biol. 1993. PMID: 8240833 Review.
Cited by
- Association of the CUN-BAE body adiposity estimator and other obesity indicators with cardiometabolic multimorbidity: a cross-sectional study.
Chen X, Geng S, Shi Z, Ding J, Li H, Su D, Cheng Y, Shi S, Tian Q. Chen X, et al. Sci Rep. 2024 May 8;14(1):10557. doi: 10.1038/s41598-024-52164-7. Sci Rep. 2024. PMID: 38719889 Free PMC article. - Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies.
Stupia R, Lombardi R, Cattazzo F, Zoncapè M, Mantovani A, De Marco L, Mantovani A, Fracanzani AL, Sacerdoti D, Dalbeni A. Stupia R, et al. J Thromb Thrombolysis. 2024 Feb;57(2):330-336. doi: 10.1007/s11239-023-02912-9. Epub 2023 Dec 8. J Thromb Thrombolysis. 2024. PMID: 38066387 Free PMC article. - Platelets in Non-alcoholic Fatty Liver Disease.
Dalbeni A, Castelli M, Zoncapè M, Minuz P, Sacerdoti D. Dalbeni A, et al. Front Pharmacol. 2022 Feb 18;13:842636. doi: 10.3389/fphar.2022.842636. eCollection 2022. Front Pharmacol. 2022. PMID: 35250588 Free PMC article. Review. - Most Women with Previous Gestational Diabetes Mellitus Have Impaired Glucose Metabolism after a Decade.
Wahlberg J, Ekman B, Arnqvist HJ. Wahlberg J, et al. Int J Mol Sci. 2018 Nov 23;19(12):3724. doi: 10.3390/ijms19123724. Int J Mol Sci. 2018. PMID: 30477103 Free PMC article. - Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis.
Baudart P, Louati K, Marcelli C, Berenbaum F, Sellam J. Baudart P, et al. RMD Open. 2017 Aug 29;3(2):e000442. doi: 10.1136/rmdopen-2017-000442. eCollection 2017. RMD Open. 2017. PMID: 29435358 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical